Yonsei Institute of Pharmaceutical Sciences, College of Pharmacy, Yonsei University, Veritas Hall D 306, 85 Songdogwahak-ro, Incheon 21983, Korea.
Department of Medical Laboratory Sciences, University of Health and Allied Sciences, PMB 31, Ho, Ghana.
Int J Mol Sci. 2022 Jan 21;23(3):1155. doi: 10.3390/ijms23031155.
Cancer has long been considered a genetic disease characterized by a myriad of mutations that drive cancer progression. Recent accumulating evidence indicates that the dysregulated metabolism in cancer cells is more than a hallmark of cancer but may be the underlying cause of the tumor. Most of the well-characterized oncogenes or tumor suppressor genes function to sustain the altered metabolic state in cancer. Here, we review evidence supporting the altered metabolic state in cancer including key alterations in glucose, glutamine, and fatty acid metabolism. Unlike genetic alterations that do not occur in all cancer types, metabolic alterations are more common among cancer subtypes and across cancers. Recognizing cancer as a metabolic disorder could unravel key diagnostic and treatments markers that can impact approaches used in cancer management.
长期以来,癌症一直被认为是一种遗传疾病,其特征是存在多种驱动癌症进展的突变。最近越来越多的证据表明,癌细胞中失调的代谢不仅仅是癌症的一个标志,而可能是肿瘤的根本原因。大多数特征明确的癌基因或抑癌基因的功能是维持癌症中改变的代谢状态。在这里,我们综述了支持癌症中改变的代谢状态的证据,包括葡萄糖、谷氨酰胺和脂肪酸代谢的关键改变。与并非所有癌症类型中都发生的遗传改变不同,代谢改变在癌症亚型和癌症之间更为常见。将癌症视为一种代谢紊乱,可以揭示关键的诊断和治疗标志物,这些标志物可能会影响癌症管理中所使用的方法。